Access to anti-retroviral drugs, female in Gambia
Gambia: Access to anti-retroviral drugs, female was 55.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Gambia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Gambia recorded 55.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
That represents a change of up 5.8% on the previous year and up 139.1% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Gambia peaked at 55.0% in 2024 and was at its lowest, 0.0%, in 2000.
Gambia ranks 111th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Gambia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 2.0% | — |
| 2006 | 2.0% | +0.0% |
| 2007 | 3.0% | +50.0% |
| 2008 | 4.0% | +33.3% |
| 2009 | 5.0% | +25.0% |
| 2010 | 10.0% | +100.0% |
| 2011 | 17.0% | +70.0% |
| 2012 | 20.0% | +17.6% |
| 2013 | 20.0% | +0.0% |
| 2014 | 23.0% | +15.0% |
| 2015 | 25.0% | +8.7% |
| 2016 | 30.0% | +20.0% |
| 2017 | 35.0% | +16.7% |
| 2018 | 38.0% | +8.6% |
| 2019 | 42.0% | +10.5% |
| 2020 | 41.0% | -2.4% |
| 2021 | 44.0% | +7.3% |
| 2022 | 48.0% | +9.1% |
| 2023 | 52.0% | +8.3% |
| 2024 | 55.0% | +5.8% |
Gambia compared with similar countries
- Gambia's 55.0% is below the median for low income countries, which is 75.5%, 73% of the median. (24 countries reporting)
- Gambia's 55.0% is below the median for Sub-Saharan Africa, which is 88.5%, 62% of the median. (44 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female in Gambia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2010 | +100.0% | 5.0% | 10.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.6% | 0.0% | 5.0% | 10 |
| 2010s | 26.0% | 10.0% | 42.0% | 10 |
| 2020s | 48.0% | 41.0% | 55.0% | 5 |
Countries ranked near Gambia
More gender data for Gambia
- Child population (UN estimates and projections) 1,149 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.4019 % change on previous year (2030)
- Population 1,981 (2030)
- Working-age population (UN estimates and projections) 1,981 (2030)
- Population (UN estimates and projections), annual growth rate 2.94 % change on previous year (2030)
- Age population, age 00, female, interpolated 39,680 (2025)
- Age population, age 00, male, interpolated 40,675 (2025)
- Age population, age 01, female, interpolated 39,327 (2025)
- Age population, age 01, male, interpolated 40,247 (2025)
- Age population, age 02, female, interpolated 38,827 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Gambia?
- Access to anti-retroviral drugs, female in Gambia was 55.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Gambia?
- The highest recorded value was 55.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Gambia?
- The lowest recorded value was 0.0% in 2000.
- How does Gambia rank for access to anti-retroviral drugs, female?
- Gambia ranks 111th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Gambia?
- Over the last ten years it is up 139.1%. The long-run trend across the full record is volatile.
- Where does this Gambia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.